The FDA announced on Oct. 1, 2014, that Hospira Inc. voluntarily recalled Hydromorphone Hydrochloride Injection due to a lack of sterility assurance caused by broken or cracked vials. The recall affects approximately 145,600 vials distributed nationwide.
How to tell if you have it
- Brand: Hospira
- Product: Hydromorphone Hydrochloride Injection, USP, 10 mg/mL
- NDC 0703-0110-01 (1 mL Single-dose Vial)
- NDC 0703-0110-03 (10 x 1 mL Single-dose Vials per carton)
- NDC 0409-2634-01 (10 x 1 mL Single-dose Vials per carton)
- Lot #a) 260753F, Exp 1FEB2015; 261403F, Exp 1FEB2015; 290153F, Exp 1MAY2015
- Lot #b) 24-080-DD, Exp 1DEC2014; 25-475-DD, Exp 1JAN2015
The hazard
The recall addresses confirmed customer complaints of glass product container vials that may be broken or cracked, resulting in a lack of assurance of sterility. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Hospira Inc. has had 108 other recalls since April 5, 2012. Other recent recalls include the April 21, 2017, Hospira Infant Dextrose Injection recall for hair particulates and the Nov. 1, 2016, Hospira Fentanyl Injection recall for broken ampule tips. Similar recent recalls of similar products include the April 2, 2026, Huons Lidocaine HCl Injection recall and the Sept. 24, 2026, Apothecary Pharma Tirzepatide Injection recall.